Skip to main content
. 2018 Jan 8;35(1):56–71. doi: 10.1007/s12325-017-0650-4

Fig. 1.

Fig. 1

CONSORT flow chart for the FULFIL study. BUD/FOR budesonide/formoterol, FF/UMEC/VI fluticasone furoate/umeclidinium/vilanterol, ITT intent-to-treat